文献速递临床试验与 GCP真实世界研究与卫生经济

治疗师指导的互联网行为治疗对抽动秽语综合征儿童及青少年的疗效与成本效果:单盲随机对照试验研究方案

Efficacy and cost-effectiveness of therapist-guided internet-delivered behaviour therapy for children and adolescents with Tourette syndrome: study protocol for a single-blind randomised controlled trial.
PubMed 文献 · Trials · 2021-09-30

本研究为单盲优势随机对照试验方案,计划纳入220名9-17岁瑞典抽动秽语综合征或慢性抽动障碍患者,随机接受10-12周治疗师支持的互联网暴露与反应预防行为治疗或互联网教育对照。主要终点为3个月随访时耶鲁全球抽动严重程度量表总分,并评估12个月疗效持久性及成本效果。

要点

  • 互联网行为治疗可克服治疗师短缺和就诊距离障碍。
  • 主要结局为3个月随访时抽动严重程度量表总分。
  • 同时评估12个月疗效持久性和短期、长期成本效果。

核心结论

  • 该方案旨在评估互联网行为治疗BIP TIC相较于主动对照的临床疗效与成本效果。

研究设计与样本

  • 单盲优势随机对照试验,计划纳入220名9-17岁瑞典抽动秽语综合征或慢性抽动障碍患者。
  • 干预为10-12周治疗师支持的互联网暴露与反应预防行为治疗,对照为治疗师支持的互联网教育。
  • 数据收集于基线、治疗第3和5周、治疗后及治疗后3、6、12个月,主要终点为3个月随访。

主要发现

  • 原文未报告结果数据。

关键数值与推荐

  • 主要结局为耶鲁全球抽动严重程度量表总分。
  • 治疗反应定义为主要终点时临床总体印象改善量表评分为「非常明显改善」或「明显改善」。
  • 所有评估点结局评估者对治疗分组设盲。

临床怎么用

  • 若证实有效,互联网行为治疗可增加抽动障碍患者获得行为治疗的机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment guidelines recommend behaviour therapy (BT) for patients with Tourette syndrome (TS) and chronic tic disorder (CTD). However, BT is rarely accessible due to limited availability of trained therapists and long travel distances to specialist clinics. Internet-delivered BT has the potential of overcoming these barriers through remote delivery of treatment with minimal therapist support. In the current protocol, we outline the design and methods of a randomised controlled trial (RCT) evaluating an internet-delivered BT programme referred to as BIP TIC. The trial's primary objective is to determine the clinical efficacy of BIP TIC for reducing tic severity in young people with TS/CTD, compared with an active control intervention. Secondary objectives are to investigate the 12-month durability of the treatment effects and to perform a health economic evaluation of the intervention. METHODS: In this single-blind superiority RCT, 220 participants (9-17 years) with TS/CTD throughout Sweden will be randomised to 10-12 weeks of either therapist-supported internet-delivered BT based on exposure with response prevention (BIP TIC) or therapist-supported internet-delivered education. Data will be collected at baseline, 3 and 5 weeks into the treatment, at post-treatment, and 3, 6, and 12 months post-treatment. The primary endpoint is the 3-month follow-up. The primary outcome is tic severity as measured by the Yale Global Tic Severity Scale - Total Tic Severity Score. Treatment response is operationalised as scores of "Very much improved" or "Much improved" on the Clinical Global Impression - Improvement scale, administered at the primary endpoint. Outcome assessors will be blind to treatment condition at all assessment points. A health economic evaluation of BIP TIC will be performed, both in the short term (primary endpoint) and the long term (12-month follow-up). There are no planned interim analyses. DISCUSSION: Participant recruitment started on 26 April 2019 and finished on 9 April 2021. The total number of included participants was 221. The final participant is expected to reach the primary endpoint in September 2021 and the 12-month follow-up in June 2022. Data analysis for the primary objective will commence after the last participant reaches the primary endpoint. TRIAL REGISTRATION: ClinicalTrials.gov NCT03916055 . Registered on 16 April 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Andrén P, Fernández de la Cruz L, Isomura K, et al. Efficacy and cost-effectiveness of therapist-guided internet-delivered behaviour therapy for children and adolescents with Tourette syndrome: study protocol for a single-blind randomised controlled trial. Trials. 2021. PMID: 34593015. doi:10.1186/s13063-021-05592-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。